{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:40:27Z","timestamp":1790991627243,"version":"4.1.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T00:00:00Z","timestamp":1650067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,29]]},"abstract":"<jats:p>Finkel and Benatar highlight the ambiguity of the term \u2018pre-symptomatic\u2019 when characterizing infants at genetic risk for spinal muscular atrophy. They propose a conceptual framework that recognizes clinically silent and prodromal stages of pre-symptomatic disease and also accommodates emerging prognostic biomarkers.<\/jats:p>","DOI":"10.1093\/brain\/awac125","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T03:13:49Z","timestamp":1648523629000},"page":"2247-2249","source":"Crossref","is-referenced-by-count":40,"title":["Pre-symptomatic spinal muscular atrophy: a proposed nosology"],"prefix":"10.1093","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-7054","authenticated-orcid":false,"given":"Richard S","family":"Finkel","sequence":"first","affiliation":[{"name":"Center for Experimental Neurotherapeutics, St. Jude Children\u2019s Research Hospital , Memphis, TN 38105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-5135","authenticated-orcid":false,"given":"Michael","family":"Benatar","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Miami , Miami, FL 33136 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,16]]},"reference":[{"key":"2022072919095627600_awac125-B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/awab404","article-title":"Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases","volume":"145","author":"Benatar","year":"2022","journal-title":"Brain"},{"issue":"12","key":"2022072919095627600_awac125-B2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","article-title":"Spinal muscular atrophy\u2014insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"2022072919095627600_awac125-B3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study","volume":"29","author":"De Vivo","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"2022072919095627600_awac125-B4","first-page":"S950","article-title":"Onasemnogene abeparvovec for presymptomatic infants with spinal muscular atrophy and two copies of SMN2: A phase III study","volume":"28","author":"Strauss","year":"2021","journal-title":"Eur J Neurol"},{"key":"2022072919095627600_awac125-B5","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.nmd.2021.07.315","article-title":"RAINBOWFISH: A study of risdipalm in infants with presymptomatic spinal muscular atrophy (SMA)","volume":"31","author":"Servais","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"578","key":"2022072919095627600_awac125-B6","doi-asserted-by":"crossref","first-page":"eabb6871","DOI":"10.1126\/scitranslmed.abb6871","article-title":"Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA","volume":"13","author":"Kong","year":"2021","journal-title":"Sci Transl Med"},{"issue":"11","key":"2022072919095627600_awac125-B7","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1172\/JCI124120","article-title":"Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment","volume":"129","author":"Ramos","year":"2019","journal-title":"J Clin Invest"},{"issue":"3","key":"2022072919095627600_awac125-B8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2022072919095627600_awac125-B9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acn3.283","article-title":"Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study","volume":"3","author":"Kolb","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"2022072919095627600_awac125-B10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.omtm.2021.10.011","article-title":"Implications of circulating neurofilamentsfor spinal muscular atrophytreatment early in life: A case series","volume":"23","author":"Alves","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"5","key":"2022072919095627600_awac125-B11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a potential biomarker for spinal muscular atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awac125\/43968442\/awac125.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/7\/2247\/45191039\/awac125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/7\/2247\/45191039\/awac125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T19:11:50Z","timestamp":1659121910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/7\/2247\/6569229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,16]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4,16]]},"published-print":{"date-parts":[[2022,7,29]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awac125","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,4,16]]}}}